中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [10]
采集方式
OAI收割 [10]
内容类型
期刊论文 [10]
发表日期
2022 [5]
2021 [5]
学科主题
筛选
浏览/检索结果:
共10条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
发表日期升序
发表日期降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
期刊论文
OAI收割
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 卷号: 21
作者:
Chen, Keyu
;
Wu, Jiayi
;
Fang, Ziru
;
Shao, Xiying
;
Wang, Xiaojia
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2022/12/22
early-stage breast cancer
genomic expression profiles
Oncotype DX
MammaPrint
RecurIndex
prediction tools
Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Wang, Rong
;
Ye, Weiwu
;
Chen, Zhanhong
;
Shao, Xiying
;
Cao, Wenming
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2022/12/23
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Chen, Zhanhong
;
Wang, Xiaojia
;
Huang, Jian
;
Zheng, Yabing
;
Shao, Xiying
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/23
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI.
期刊论文
OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Cao, Wen-Ming
;
Wang, Xiaojia
;
Liu, Jian
;
Wang, Lili
;
Zhang, Xiaodong
  |  
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/12/23
The characteristics and novel clinical implications of CD4+CXCR5+Foxp3+follicular regulatory T cells in breast cancer
期刊论文
OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Miao, Xianyuan
;
Guo, Qiusheng
;
Pan, Zhiwen
;
Xu, Xiaohong
;
Shao, Xiying
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2021/11/01
Breast cancer (BC)
follicular regulatory T cell (Tfr)
T-cell immunoglobulin mucin 3 (TIM-3)
Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axis
期刊论文
OAI收割
HUMAN CELL, 2021
作者:
Huang, Yuan
;
Zheng, Yabing
;
Shao, Xiying
;
Shi, Lei
;
Li, Guangliang
  |  
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2021/06/15
TPT1-AS1
Cell proliferation
Paclitaxel sensitivity
Breast cancer
CASP2
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study
期刊论文
OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Shao, Xiying
;
Zheng, Yabing
;
Cao, Wenming
;
Shen, Xiabo
;
Li, Guangliang
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2021/06/15
Ki67
progesterone receptor
palbociclib
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review
期刊论文
OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Wang, Xiaojia
;
Shao, Xiying
;
Huang, Jian
;
Lei, Lei
;
Huang, Yuan
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2021/06/15
Metastatic breast cancer (MBC)
treatment
cure
molecular types
targeted therapy
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer
期刊论文
OAI收割
CANCER RESEARCH, 2021, 卷号: 81
作者:
Huang, Jian
;
Shao, Xiying
;
Cai, Li
;
Shi, Yanxia
;
Chen, Zhanhong
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2021/04/26